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Abstract.  We have generated transgenic mice by mi- 
croinjection of a  39-kb mouse procd(II) collagen 
gene construct containing a deletion of exon 7 and in- 
tron 7.  This mutation was expected to disturb the as- 
sembly and processing of the homotrimeric type II 
collagen molecule in cartilage.  Expression of transgene 
mRNA at levels equivalent or higher than the endoge- 
nous mRNA in the offspring of two founder animals 
resulted in a  severe chondrodysplastic phenotype with 
short limbs, hypoplastic thorax, abnormal craniofacial 
development, and other skeletal deformities.  The af- 
fected pups died at birth due to respiratory  distress. 
Light microscopy of epiphyseal growth plates of trans- 
genie pups demonstrated a marked reduction in car- 
tilaginous extracellular matrix and disruption of the 
normal organization of the growth plate.  The zone of 
proliferating chondrocytes was greatly reduced whereas 
the zone of hypertrophic chondrocytes was markedly 
increased extending deep into the diaphysis sugges- 
tive of a defect in endochondral ossification.  Elec- 
tron microscopic examination  revealed chondrocytes 
with extended RER, a very severe reduction in the 
amount of cartilage collagen fibrils, and abnormal- 
ities in their structure.  We postulate that the deletion 
in the t~l(II) collagen acts as a dominant negative mu- 
tation disrupting the assembly and secretion of type II 
collagen molecules. The consequences of the mutation 
include interference with normal endochondral  ossi- 
fication.  These mice constitute a valuable model to 
study the mechanisms underlying human chondrodys- 
plasias and normal bone formation. 
T 
YPE II collagen, a homotrimer of ot 1  (II) chains,  is the 
predominant  protein in cartilage matrix.  The  func- 
tional  form of type II collagen  in most hyaline  car- 
tilages  is  a  thin  fibril  (10-50  nm  in  diameter)  in  which 
individual  molecules  associate  laterally  and  head-to-tail 
with each other and with type XI and type IX collagen mole- 
cules (Mayne and vonder Mark, 1983; Mender et al., 1989; 
Hunziker and Herrmann,  1990).  The fibrils confer tensile 
strength  and provide a  scaffolding  network for proteogly- 
cans.  Like for other fibrillar  collagens the important struc- 
tural characteristics of type II collagen include the presence 
of glycine residues as every third  amino acid throughout 
the triple helical domain and conservation of  the length of the 
triple helical  domain (Vuorio and de Crombrugghe,  1990; 
Metstiranta  et al.,  1991). These features are critical  for the 
formation of the triple helix, its stability, and collagen fibril 
assembly. Any change in these properties is likely to disturb 
either the formation of the triple helix or fibrillogenesis,  as 
appears to be the case with mutations in the genes coding 
for type I collagen, which cause various forms of osteogene- 
sis imperfecta and Ehlers Danlos syndrome (Byers,  1989; 
Prockop et al.,  1990).  Given the many lateral  associations 
between the polypeptide chains in the procollagen molecules 
and between collagen molecules in the fibrils, mutations in 
the triple helical domain of type II collagen are expected to 
be dominant. 
In an adult organism type II collagen is mainly found in 
the hyaline cartilage of articular surfaces and the nucleus pul- 
posus of the intervertebral  discs.  Earlier in life the growth 
of long bones, which largely determines skeletal size, occurs 
at growth plates by production of cartilage  matrix by chon- 
drocytes (Stockwell, 1979; Sandberg and Vuorio,  1987). In 
addition to these structural  roles cartilage  matrix also func- 
tions during embryonic development as a model for bone for- 
marion through endochondral  ossification.  During develop- 
ment transient  type II collagen  expression  also occurs at 
several epitheliomesenchymal  interfaces  of the craniofacial 
system as well as in the tail tendon,  heart,  epidermis,  and 
brain (Thorogood et al., 1986; Cheah et al., 1991; Wood et 
al., 1991). The significance of this transient  synthesis is not 
yet understood. 
The phenotypes of diseases in which linkage to the type 
II collagen gene has been identified are clearly related to ei- 
ther disturbed long bone growth or degeneration  of articular 
￿9  The Rockefeller University Press, 0021-9525/92/07/203/10 $2.00 
The Journal of Cell Biology, Volume 118, Number 1, July 1992 203-212  203 surfaces,  i.e.,  osteoarthrosis  (Francomano  et  al.,  1987; 
Palotie et at., 1989; Knowlton et al., 1990). Genetic defects 
in type II collagen have been identified at the nucleotide level 
in some chondrodysplasias representing variable symptoma- 
tologies from lethal type II (La_nger-Saldino) achondrogene- 
sis (Vissing et al., 1989), to less severe syndromes such as 
hypochondrogenesis, spondyloepiphyseal dysplasia (SEE)), 
congenita (Lee et al., 1989; Tiller et al., 1990), and Stickler 
syndrome (Ahmad et al., 1991), and in osteoarthrosis (Ala- 
Kokko et al.,  1990).  The diversity of these phenotypic ab- 
normalities clearly demonstrates that mutations in type II 
collagen can have very different consequences.  In humans 
the functional domains of type II collagen can only be de- 
fined by characterizing rare and often sporadic mutations. 
Therefore transgenic mice are well suited to study the func- 
tional anatomy of the molecule in a  more systematic way. 
Chondrocyte  proliferation and production of extracellular 
matrix play central roles at growth plates during long bone 
growth, but the contribution of individual components to the 
process is poorly understood.  The introduction of mutated 
type II collagen genes into the mouse germ line can generate 
abnormal phenotypes caused by loss of function of normal 
collagen, and provide a way to understand consecutive alter- 
ations in other matrix components. This was recently shown 
for a point mutation which changed the glycine residue at po- 
sition 85 of the triple helical domain of type II collagen to 
a cysteine residue and caused a chondrodysplastic phenotype 
(Garofato et al.,  1991). 
In this study we have generated transgenic mice strains by 
microinjection of a  mouse type II collagen gene carrying a 
150-bp deletion including the 45-bp exon 7.  Expression of 
the transgene results in a  very severe depletion of collagen 
fibrils in cartilages which presumably causes the pronounced 
short  limbed  dwarfism  and  other  skeletal  abnormalities, 
many of which resemble those seen in human chondrodys- 
plasias. The histological and ultrastructural characteristics 
of these mice are distinctly different from those seen in mice 
harboring the glycine-85 substitution mutation. 
Materials and Methods 
Gene Constructions 
The entire mouse pro~t(lI) collagen gene was sequenced beforv mutagene- 
sis (Metsiiranta et al., 1991). The single ClaI site within the gone and the 
Clal site in cosmid 15WEI5  close to the cloning site made it possible to con- 
struct cosmid clones p8045 and p8023 containing the 5' and 3' portions of 
the gone with 3 and 7 kb of flanking sequences, respectively (Fig. 1). The 
mutation was introduced into cosmid clone p8045 by replacing the wild- 
type PstI-ECORI  fragment with the corresponding mutated fragment (Fig. 
1, A-C). The 800-bp PstI-EcoRI fragment was first removed  from a 2.2-kb 
wild-type  Kpnl-EcoRI  genomic fragment (Fig. 1  A). The clone was digested 
with Apal and the 150-bp ApaI fragment removed (Fig. 1 B). Generation 
of  this deletion was based on the presence of two ApaI sites, one at the be- 
ginning of  exon 7 and one at the beginning  of  exon 8, both in the same read- 
ing frame (gGGCCC, Mets~anta et al., 1991). This deletion also removed 
an NcoI site in exon 7. The resulting size difference  and the NcoI polymor- 
phism provided  simple methods  for detection  of  the transgene  over the back- 
ground of the endogenous type II collagen genes (Fig. 2). The shortened 
(650 bp) PstI-EcoRI fragment was recloned into the 2.2-kb KpnI-EcoRI 
fragment (Fig. 1 C) followed  by insertion of a reconstituted 1.9-kb XhoI- 
XhoI fragment into the 13-kb NotI-ClaI subclone p8045 (Fig. 1 D). The 
mutation and the orientation of the fragment were confirmed by DNA se- 
quencing using specific  oligonucleotide  primers. Reconstruction  of  the gene 
was completed by addition of the 26-kb ClaI-ClaI fragment of 108023 con- 
taining the 3' half of the gene (Fig. 1 E). The orientation of the insert was 
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Figure 1. Schematic representation of the construction of the mu- 
tated transgene. The deletion of exon 7 was generated by removal 
of a  150-bp ApaI fragment containing exon 7 and intron 7 (A and 
B). The resulting shortened PstI-EcoRI fragment was subeloned 
back into the wild-type clone (2.2-kb KpnI-EcoRI fragment) fol- 
lowed by subsequent cloning of a t.9-kb XhoI-XhoI fragment into 
p8045 containing the 5' half of the mouse type II collagen gene (C 
and D). Reconstruction of the gene was completed by addition of 
the 26-kb ClaI-ClaI fragment p8023 containing the 3' half of the 
gene (E). EcoRI restriction map of the reconstructed gene (F and 
G) shows the structural portion of the procd(ID collagen gene as 
the solid rectangle. The insert containing the reconstituted gene 
was liberated from the cosmid vector with NotI digestion. 
verified by restriction mapping. The insert containing the reconstituted 
gene, 3 kb of promoter sequences and 7 kb of 3' flanking sequences (Fig. 
I F) was liberated from the cosmid vector with NotI digestion, purified, 
and used for microinjection. 
Generation and Identification of Transgenic Mice 
Mouse oocytes w~re isolated from B6D2FI females mated with B6D2H 
males as described (Hogan et al., 1986). DNA was microinjected into 
pronuclei of one-cell embryos and the surviving embryos were implanted 
into CD1 pseudopregnant  foster mothers. The transgenic  founders  were ini- 
tially identified by polymerase chain reaction (PCR)  l analysis of genomic 
tail DNA using primers A4 in exon 6 and A5 in exon 8 which flank the dele- 
tion mutation (Fig. 2; Garofalo et al., 1991). The amplification  conditions 
for PCR were 94"C for 1 min, 57~  for 2 rain, and 720C for 3 rain for 
30 cycles. The number of integrated transgene copies was determined by 
Southern analysis using the 800-bp PstI-EeoRI ganomic fragment (Fig. 1 
A) as probe. For Southern analyses of the EcoRl digested DNAs the entire 
type II collagen  cosmid clone p804 was used as probe. Because of  the pres- 
ence of repetitive sequences within the gene mouse genomic DNA was 
added to the hybridization solution (Sambrook et al., 1989) to a final con- 
centration of 100 t~g/ml. 
Preparation and Analysis Of  RNA 
Total RNA was isolated from several mouse tissues by homogenization  in 
4 M guanidine isothiocyanate followed by sedimentation through 5.7 M 
cesium cloride (Chirgwin et al., 1979). Determination of  the ratio of  trans- 
gene derived mRNA and wild-type mRNA for prootl(II)  collagen was per- 
i. Abbreviation used in this paper: PCR, potymerase chain reaction. 
The Journal of C  el! Biology, Volume I18, 1992  204 Figure 2.  Identification of transgenic mice by Southern analysis. (A) Schematic representation of wild-type and mutated gene structures 
and Ncol sites near the mutation site. The presence of the transgene in the mouse genome results in a  1,018-bp NcoI fragment while the 
endogenous gene is represented by 628 and 540 bp fragments. (B) Detection of transgene by Southern analysis after NcoI digestion. Tail 
DNA samples (10 #g) were digested with NcoI, fractionated on a  1%  agarose gel,  and blotted onto a Hybond-N membrane. The blot 
was hybridized with a 32P-labeled  800-bp PstI-EcoRI fragment (see Fig.  1 C) which spans from the middle of intron 6 to intron 8 (A). 
The samples in B are: (lane 1 ) nontransgenic control; (lanes 2 and 3) positive offspring of founder Del 3; (lane 4) nontransgenic control; 
(lane 5) founder Del3; (lane 6) founder Del2; (lane 7) founder Dell; (lane 8) heterozygous offspring of Dell founder; and (lanes 9 and 
10) homozygous offspring of Dell founder. (C) Southern analysis of the entire type II collagen gene in the offspring of transgenic founder 
animals. Aliquots of transgene construct and tail DNA samples (10 #g) were digested with EcoRI, fractionated on a 0.7% agarose gel, 
and analyzed by Southern hybridization using the entire 32p-labeled  wild-type gene as probe. The samples are: founder Dell (lane 1); 
nontransgenic control (lane 2); positive offspring of founder Del3 (lane 3); founder Del2 (lane 4); and aliquots of the transgene construct 
corresponding to 1, 10, and 20 copies per diploid genome (lanes 5-7, respectively). The 2.2- and 0.5-kb terminal fragments of the construct 
fuse in a head-to-tail integration into a  band migrating with the 2.4-kb fragment. In the wild-type gene the 5' end migrates as a 4.7-kb 
EcoRI band with the 5-kb integral EcoRI fragment, pWE15 marks the vector band which is only present in the copy number controls. 
The hybridization pattern confirms the presence of the entire transgene in the mouse lines with no indication of rearrangements. 
formed using an RNase protection assay (Sambrook et al.. 1989). A linear- 
ized eDNA clone covering sequences from exon 5B to exon 8 (Mets~iranta 
et al., 1991) was used as a template for the synthesis of antisense RNA using 
T7 polymerase and 32P-UTP. Full length transcripts were purified on a de- 
naturing polyacrylamide gel. Solution hybridization was performed at 55~ 
using 2  x  10  s cpm of robe and 10 #g of total RNA. After hybridization 
the samples were digested with RNase A and T1, and proteinase K, and 
precipitated for electrophoresis on denaturing 8% polyacrylamide gels. Af- 
ter fixation and drying the gels were exposed with x-ray films and quantified 
using a betascan counter. 
~ssue Preparation, Histology, 
and Electron Microscopy 
To obtain fresh tissue samples for light and electron microscopy embryos 
were removed by Cesarean section at 18.5-19.5 d. For visualization of the 
entire skeleton of transgenic mice and their nontransgenic littermates 19.5-d 
embryos were stained with alcian blue and alizarin red S (McLeod, 1980). 
Routine histology  was  performed  on tissues  that  were fixed in 4% 
buffered formaldehyde, embedded in paraffin, sectioned, and stained with 
hematoxylin and eosin. 
The samples for EM were dissected immediately after the death of the 
mice. The forelimbs were immersed in 1.5 % glutaraldehyde, 1.5% parafor- 
maldehyde, and 0.5% ruthenium hexamine trichloride in 0.1 M cacodylate 
buffer, pH 7.3. During this initial stage of fixation the long bones were re- 
moved by dissection under a magnification of 6.4 and were then fixed for 
3 h in a fresh aliquot of the primary fixative. Subsequently, after several 
brief rinses in cacodylate buffer, the long bones were postfixed in 1.0% os- 
mium tetroxide in cacodylate buffer. The specimens were dehydrated, em- 
bedded in Spurr's resin, sectioned, and stained with 4% uranyl acetate and 
Reynold's lead citrate, 
Results 
Generation of Transgenic Mice 
Three transgenic founder mice were generated by microin- 
jection of the gene construct into fertilized oocytes. DNA 
was  isolated  from  tails  of putative  founder  animals  for 
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analysis two oligonucleotide primers (containing sequences 
in exons 6  and 8,  respectively; Fig.  2 A) were used.  The 
transgene fragment was easily detected because of its smaller 
size (750 vs 900 bp). The findings were confirmed by South- 
ern blot hybridization which also allowed determination of 
the number of transgene copies integrated into the genome 
of founder animals. Digestion of genomic DNA with NcoI 
resulted in a diagnostic 1,018-bp transgene fragment and two 
endogenous 628 and 540 bp gene fragments in Southern hy- 
bridization (Fig.  2  B).  To demonstrate the successful in- 
tegration of the entire transgene into the genome of founder 
Figure 3. Chondrodysplastic phenotypes of transgenic mice. (A) A 19.5-d transgenic Del3 embryo (left) and its nontransgenic littermate 
(right).  (B) Skeleton of 19.5-d Del3 embryo (left) and its nontransgenic littermate (right)  stained with alcian blue and alizarin red S. 
Shortening of the long bones is evident in the forelimbs of 19.5-d heterozygous (D) and homozygous (E) Dell embryos when compared 
with their nontransgenic littermate (C), and in the forelimb of a 19.5-d Del3 embryo (G) compared with its nontransgenic littermate (F). 
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genomic DNAs  were performed.  Using the entire mouse 
cd(II) collagen gene as probe no differences were observed 
in the genomic fragments when compared with the normal 
mouse al(II) collagen gene or the cosmid clone, demonstrat- 
ing that no gross rearrangement had occurred during the in- 
tegration of the transgene in the mouse genome (Fig. 2 C). 
Three founder animals carrying the transgene were detected. 
In quantitative analysis of the  Southern blots  the  female 
founder (Dell) was found to have approximately six copies 
of the transgene in its genome and the two  male found- 
ers (Del2 and Del3) one and four copies, respectively (Fig. 
2  C). 
None  of the  founder  animals  exhibited  any  abnormal 
phenotype except for a smaller size of founder Dell. How- 
ever,  all transgenic offspring of founder Del3 had a severe 
form of  short-limbed dwarfism (Fig. 3) and died shortly after 
birth due to respiratory distress. The animals attempted to 
breathe, but were unable to ventilate their lungs (Fig. 4 D). 
The animals became cyanotic and unresponsive to external 
stimuli and died shortly afterwards.  In addition to  short 
limbs  these  mice  displayed  a  shortened  axial  skeleton, 
hypoplastic thorax, distended abdomen, short snout, pro- 
truding tongue, and cleft palate (Figs.  3 and 4).  Southern 
analysis of the transgenic offspring of founder Del3 showed 
a higher copy number (15 copies) of the transgene than the 
founder (four copies;  Fig.  2,  B  and  C).  These  analyses 
proved that the Del3 founder was mosaic for the transgene, 
which probably explains its normal phenotype. 
The Dell  founder and its F1 offspring (six copies of the 
transgene) did not show any phenotypic abnormality other 
than a smaller size. Mating of  positive Fl mice has generated 
mice homozygous for the transgene (12 copies) which all 
have a severe short-limbed dwarfism similar to that seen in 
Del3 offspring (Figs. 3 and 4). The offspring of Dell founder 
will  subsequently  be  referred  to  as  heterozygous  and 
homozygous Dell pups, respectively. No abnormalities have 
been observed in the heterozygous and homozygous  progeny 
of founder Del2; therefore, these have not yet been studied 
further. 
Expression of the Mutant Transgene 
To determine whether the transgene was specifically tran- 
scribed in the cartilage of the affected mice total RNA was 
isolated from limbs of normal and transgenic mice. Since the 
transgene is identical to the endogenous mouse gene except 
for the 150-bp deletion, the transgene derived mRNA had to 
be distinguished from the wild-type od(II) collagen mRNA 
on the basis of its smaller size (45 nucleotides) using either 
RNAse protection experiments or amplification by  PCR. 
Specific  oligonucleotide  primers  bracketing  the  deletion 
Figure 4. Additional phenotypic abnormalities in Del3 transgenic offspring. Cleft palate in a 19.5-d homozygous Dell embryo (B) and 
the normal palate of its nontransgenic littermate (,4). A transverse section of the head of DeI3 newborn mouse demonstrating the tongue 
obstructing the closure of palatal ridges (C). Histological section through the thorax reveals the inflated lung of a nontransgenic mouse 
(D), and the collapsed lung of a newborn Del3 transgenic mouse (E).  Bars, 200 gm. 
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of the  ratio  of transgene-derived mRNA  and wild-type 
mRNA for prot~l (II) chains was performed by RNase pro- 
tection analysis. The 315-bp 32p-labeled antisense probe 
(lane 1) was bybridized to total RNA from limb cartilages 
of Dell heterozygous (lane 2) and homozygous  pups (lanes 
3 and 4), a Del3 embryo (lane 5), and its nontransgenic 
littermate (lane 6), followed by digestion with RNase A 
and T1 and electrophoresis on a denaturing 8 % acrylamide 
gel with end-labeled MspI fragments of pBR322 as stan- 
dards (lane 7).  The size of the protected wild-type frag- 
ment is 243 bp, and that derived from the transgene 144 
bp. (B) Tissue specificity of transgene expression was ana- 
lyzed by RNase protection using total  RNA from brain 
(lane 1 ), heart (lane 2), intestine (lane 3), kidney (lane 4 ), 
liver (lane 5), lung (lane 6), skin (lane 7), eyes (lane 8), 
calvaria (lane 9), rib cartilages (lane 10), and limb car- 
tilages (lane 11 ). The undigested probe was run in lane 12. 
(C) Overexposure of the same filter to demonstrate low 
abundancy mRNAs. 
were used in the PCR amplification of cDNA synthesized by 
reverse transcriptase for cartilage RNA of transgenic mice. 
These analyses suggested that expression of  both the endoge- 
nous gene and the transgene occurred predominantly in car- 
tilage and eye. However, low levels of both transcripts, prob- 
ably  related  to  illegitimate  transcription  (Chelly  et  al., 
1989), were detected in all RNA samples studied (data not 
shown). 
Quantitation of transgene expression was performed using 
an RNase protection assay.  With an antisense RNA probe 
spanning the deletion the ratio of transgene-derived mRNA 
and endogenous prood(II) collagen mRNA was determined 
in the same reaction (Fig. 5 A). The results indicate that in 
the severely affected Del3 pups the average ratio of  transgene 
RNA to prood(II) collagen mRNA was 1.9. The correspond- 
ing ratios for homozygous and heterozygous Dell pups were 
1.5 and  1.2,  respectively. 
Analysis of RNAs isolated from several other tissues of 
transgenic mice demonstrated the tissue specificity of trans- 
gene expression (Fig.  5,  B  and  C).  The highest levels of 
transgene-  and  endogenous gene-derived transcripts  were 
seen in limb and rib cartilages, followed by calvaria and eye 
RNA. In skin the ratio of the transgene to endogenous gene 
expression was clearly increased over what was seen in carti- 
lage. With this exception the construct used for microinjec- 
tion appears to contain the elements necessary for tissue- 
specific expression. 
Structure and Ultrastructure of the Cartilage 
The most dramatic effect of the transgene in the affected 
offspring of DeU and Del3 founders was the abnormal devel- 
opment of the bony and cartilaginous skeleton as demon- 
strated by staining of whole embryos with alcian blue and 
alizarin red S (Fig. 3 B). All skeletal structures were smaller 
in the transgenic offspring of the Del3 founder than in their 
nontransgenic littermates. This was particularly evident in 
the long bones of forelimbs and hindlimbs with an average 
reduction in the length/width ratio of  40% (Fig. 3, Fand G). 
The homozygous offspring of founder Dell  demonstrated 
similar skeletal abnormalities in comparison with their non- 
transgenic littermates (25 % average reduction). In the het- 
erozygous Dell offspring the corresponding length/width ra- 
tio was reduced by an average of 15%  (Fig. 3, C-E). Since 
retarded growth of long bones was a distinct feature of the 
skeletal abnormalities we focused our attention on epiphyseal 
cartilages and growth plates. These tissues contain chondro- 
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transgenic embryo (B) and its nontransgenic littermate (A). The 
forelimbs  of  the embryos  were removed  immediately  after Cesarean 
section, fixed, and embedded. Thin sections were stained with he- 
matoxylin and eosin. The figure shows  representative views of  dis- 
tal ends of radial bones with the heights of the proliferative and 
hypertrophic zones indicated with P and H, respectively. Another 
view of a 19.5-d homozygous  Dell transgenic growth cartilage (C) 
demonstrates an acellular area in the central part of the cartilage 
seen typically in several severe Del mutant cartilages. Bar, 100/zm. 
cytes in various developmental stages with different  prolifer- 
ative and synthetic activities (Stockwell,  1979;  Sandberg 
and Vuorio,  1987). 
In  light  microscopy  the  most  striking  features  in  the 
epiphyseal and growth plate cartilages of Del3 offspring were 
the reduction in the cartilaginous extracellular matrix and 
disorganization of the characteristic architecture of the nor- 
mal growth plate (Fig. 6).  Compared with wild-type mice 
(Fig. 6 A) the Del3 and homozygous Dell offspring exhib- 
ited a marked reduction in the number of  proliferating chon- 
drocytes, an absence of the typical columnar arrangement, 
and a severalfold increase in the height of the zone of hyper- 
trophic chondrocytes (Fig. 6, B and C). The sharp line of 
demarcation at the osteochondral junction was replaced by 
deep invaginations of hypertrophic chondrocytes into the di- 
aphysis. In the transgenic mice the bone spicules were re- 
duced in numbers suggesting impaired replacement of carti- 
lage matrix by bone. On the contrary, bone formation along 
the periosteal collar of long bones was enhanced as evi- 
denced by the thickened periosteal bone extending well be- 
yond the osteochondral junctions. In Del3 and homozygous 
Dell cartilages chondrocyte hypertrophy was also observed 
in anomalous locations,  e.g.,  central parts  of the growth 
plate and epiphysis (Fig. 6 C). Strikingly, no thick bundles 
of collagen fibers, prominent in another transgenic mouse 
line with a  Gly85~Cys point mutation in the same gene 
(Garofalo et al., 1991), were seen in the cartilaginous matrix 
of the Dell or Del3 offspring. Light microscopic changes in 
heterozygous Dell mice were much milder; the main differ- 
ence seen was the increased number of hypertrophic and de- 
generating chondrocytes in growth cartilages and in anoma- 
lous locations. 
Electron microscopic examination of  the growth cartilages 
revealed a  very severe reduction in the cartilage collagen 
fibrils in Del3 and homozygous Dell pups (Fig. 7). In addi- 
tion the morphology of these fibrils was abnormal: instead 
of  the thin straight fibrils the mutant cartilages contained dis- 
organized fibrils which appeared curved or wavy (Fig. 7, F 
and H).  Collagen fibrils in heterozygous Dell  cartilages 
were only slightly reduced in amount; some of  the fibrils had 
a wavy structure analogous to those seen in the more severe 
mutants (Fig. 7 D). In all transgenic cartilages the chondro- 
cytes were found to contain prominent, dilated RER, sugges- 
tive of retention of newly synthesized molecules in the cells 
(Fig. 7,  C, E, and G). 
Discussion 
The expression of an cd(II) collagen transgene with a dele- 
tion of exon 7 has dramatic effects on the development and 
growth of the skeleton. The mutation in the od(II) collagen 
gene  causes  malfunction of the  cartilage  growth  plates, 
which results in reduced size, retarded ossification, and dis- 
proportionate growth (Figs. 3 and 6). The malfunction of the 
growth  plates  is  most  likely caused  by  reduction in  the 
amount of cartilage  extracellular  matrix,  which  is  most 
likely itself a consequence of a very marked decrease in the 
collagen fibrils (Fig. 7). This reduction in the amount of car- 
tilage fibrils, the final synthetic product of the type II colla- 
gen gene was clearly dependent on the level of transgene ex- 
pression as determined by RNase  protection experiments 
(Fig. 5). Indeed, the most severe phenotype was seen in Del3 
offspring which has the highest expression level of the trans- 
gene, a somewhat milder symptomatology in homozygous 
Dell  offspring with a  somewhat lower level of transgene- 
derived mRNA, a much milder phenotype in heterozygous 
Dell offspring, and apparently normal phenotypes in homo- 
zygous and  heterozygous Del2  offspring.  The  tissue  spe- 
cificity of transgene expression,  as  well as a  correlation 
between gene copy number and the severity of the growth 
abnormalities,  probably result from the use of the entire 
mouse gene with a substantial amount of flanking sequences 
for microinjections. Recent work on the rat type II collagen 
gene has suggested the presence of a tissue-specific enhancer 
Mets~anta et aL Chondrodysplasia in Transgenic Mice  209 Figure 7. EM of growth cartilages of 19.5-d embryos. (A, (7, E, and G) Chondrocytes in the proliferative zone of nontransgenic (A), Dell 
heterozygous (C), and homozygous (E), and Del3 offspring (G) with the corresponding views of cartilage matrix in B, D, F, and H. The 
bars in panels G  and H  show the magnification for left and right columns, respectively. Bars:  (A,  C, E, and G) 5  #m; (B, D, E  and 
H)  0.5  #m. 
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the promoter (Horton et al.,  1987; Savagner et al.,  1990). 
It is not known, however, whether the sequences in the first 
intron or other sequences in the gene are, in our experiments, 
responsible for the substantial level of tissue-specific expres- 
sion of  the transgene, which appears to be independent of  the 
site of integration. Some regulatory elements are probably 
missing from our construct since >6-7 transgene copies are 
needed before a gross growth abnormality can be observed. 
We believe that the reduction in the amount of extracellu- 
lar matrix is a direct consequence of retarded secretion of 
type II collagen molecules containing shortened a  chains. 
The stoichiometry of chain association in the homotrimeric 
type II collagen molecule makes it particularly vulnerable to 
such mutations. The presence of  one shortened a chain prob- 
ably reduces the stability of the triple helix and increases in- 
tracellular degradation of such mutant procollagen mole- 
cules. EM of chondrocytes in Del3 and homozygous Dell 
cartilages demonstrated greatly extended RER, a finding that 
is also typical of analogous mutations in type I collagen. In 
this case the distension of RER correlates with retention of 
abnormal procollagen within the cell (Dombowski et al., 
1989;  Prockop et al.,  1990).  In the mild chondrodysplasia 
of heterozygous Dell mice the extended RER was the most 
pronounced abnormality observed at electron microscopic 
level. Currently we cannot explain how these Dell chondro- 
cytes can sustain quasinormal growth while containing ap- 
proximately equal  amounts of endogenous and transgene 
mRNA since this stoichiometry suggests that considerable 
amounts of abnormal procollagen molecules are produced. 
The presence of abnormal curving or wavy fibrils seen in the 
cartilage matrix of the severely affected mice suggests a de- 
fect also in the extracellular assembly of type II collagen 
molecules into fibrils. This could be because of  the presence 
of some heterotrimeric type II collagen molecules in these 
fibrils. Alternatively, homotrimeric molecules of shortened 
al(II) chains may be secreted and incorporated into fibrils, 
their reduced length disrupting fibrillogenesis. Biochemical 
analyses on the composition of  extracellular and intracellular 
type II collagen molecules are currently in progress to clar- 
ify this point. 
The structure of cartilage collagen fibrils in the Del mu- 
tants is in striking contrast to the abnormalities seen in trans- 
genic mice harboring three other mutations which affect ei- 
ther one of the two cross-linking lysine residues, one in the 
N-telopeptide and one in amino acid 87 of the triple helix, 
or the glycine-85 residue adjacent to lysine-87.  These muta- 
tions result in the appearance of thick bundles of banded type 
II collagen fibrils throughout the cartilage matrices suggest- 
ing a major defect in the mechanism which controls the di- 
ameter of cartilage collagen fibrils (Garofalo et al., 1991; and 
unpublished observations).  No such thick fibrils were ob- 
served in the Del mutant cartilages. Recently mice harboring 
a human type II collagen transgene with a large deletion of 
12 triple helical exons were shown to have a short limbed 
dwarfism similar to the severe Del phenotype (Vandenberg 
et al., 1991). Histological analysis of these animals also re- 
vealed a marked reduction in cartilage collagen fibrils. No 
thick collagen fibrils typical for the Gly85 and cross-link 
mutants were observed. 
The most interesting aspect of  the expression of  the mutant 
transgene  is  the  marked disorganization of the  normally 
well-defined columnar architecture of proliferating, hyper- 
trophic, and degenerating chondrocytes in the growth carti- 
lage (Sandberg and Vuorio, 1987; Hunziker and Herrmann, 
1990).  We propose that the shortening of the proliferative 
zone results from inadequate production of type II collagen, 
which prevents the clonally derived chondrocytes from sep- 
arating from each other and forming typical columnar struc- 
tures. This phenomenon probably explains the greatly re- 
duced growth rate of long bones. A unique feature of  the Del 
mutation in the growth plate is the severalfold increase in the 
size of  the zone of  hypertrophic chondrocytes extending deep 
into the diaphysis of  long bones in contrast to the remarkably 
sharp line of demarcation between cartilage and invading 
bone in the normal growth plate.  The histological picture 
suggests that replacement of cartilage matrix by bone is im- 
paired in these mice. The severe reduction in collagen fibrils 
clearly causes an impairment of  the growth plate architecture 
at several levels.  The normal columnar organization of the 
proliferative chondrocytes, the  size  of the zone of hyper- 
trophic chondrocytes, and the transition zone between hy- 
pertrophic zone and the osseous zone itself are all severely 
disrupted by the diminution of  the number of  collagen fibrils. 
Our results indicate that the structural integrity of these dif- 
ferent parts of the growth plate are essential to assure normal 
skeletal growth. At least three extracellular matrix compo- 
nents have been proposed to play a role in mineralization and 
degeneration of hypertrophic cartilage. Type X collagen is 
a short-chain collagen with an extremely restricted expres- 
sion pattern limited to hypertrophic chondrocytes (Schmid 
and Linsenmayer, 1987).  In the growth plate, chondrocyte 
hypetrophy is also coincident with expression of mRNA for 
osteonectin (SPARC), a calcium binding protein (Mets/iranta 
et al., 1989). The C-propeptide of type II collagen (chondro- 
calcin) is another component which has been suggested to 
be enriched in hypertrophic cartilage and to play a regula- 
tory role (Poole et al., 1984). The production of the C-pro- 
peptide, which normally is cleaved extracellularly from se- 
creted procollagen, must be severely affected in the mutant 
Del cartilage. Although we cannot at this time explain the 
mechanisms regulating the size of the hypertrophic zone, the 
abnormal growth plates in Del mice may be valuable for such 
investigations. 
We believe that the phenotypic abnormalities in the Del3 
and Dell  transgenic  pups  result  from impaired  cartilage 
production which results in retarded bone growth. The cleft 
palate is probably a secondary consequence of retarded man- 
dibular growth which pushes the tongue upwards and pre- 
vents the normal closure of  palatal ridges (Fig. 4, A-C) (Fer- 
guson,  1988).  The  breathing  difficulties probably  result 
from obstructed air flow due to the marked weakening of car- 
tilage structure. Many of the phenotypic abnormalities we 
have seen in the severe Del3 and Dell transgenic mice resem- 
ble those seen in human chondrodysplasias. Indeed type II 
collagen mutations have recently been identified in some of 
these diseases with very different degrees of severity extend- 
ing from perinatal lethal achondrogenesis type II to mild 
spondyloepiphyseal dysplasia  with  predisposition  to  os- 
teoarthritis (Lee et al., 1989; Vissing et al., 1989; Tiller et 
al.,  1990;  Ala-Kokko et al.,  1990;  Ahmad et al.,  1991). 
While most of  the abnormalities in the Del mice (e.g., matrix 
deficiency, disorganization of the growth plate, short limbs, 
and other  skeletal  deformities) are  typical for  the  spon- 
Mets~.ranta  et al.  Chondrodysplasia  in Transgenic Mice  211 dyloepiphyseal dysplasia (SED) group of chondrodysplasias, 
the persistence of hypertrophic  chondrocytes  is a charac- 
teristic finding of opsismodysplasia,  a rare form of lethal 
chondrodysplasias  (Maroteaux et al.,  1984;  Spranger  and 
Maroteaux,  1990).  In addition to delayed bone maturation 
the abnormalities in opsismodysplasia include thoracic and 
craniofacial abnormalities and muscular hypotonia. Several 
forms of the mouse chondrodystrophies also share features 
similar to those described for the Del mice (Johnson, 1986). 
Although  the  macroscopic  phenotype  in disproportionate 
micromelia and chondrodystrophy  closely resembles that of 
severe Dell  and Del3 mutants,  the histologic findings are 
clearly distinct from ours. Further work is needed before the 
link between the human diseases, the mouse chondrodystro- 
phies, and the transgenic  mouse model can be established. 
However,  our observations  illustrate  the usefulness of the 
transgenic  mouse system to characterize both the functional 
topology of the type II collagen molecule and the dysfunction 
of growth  cartilages in human  chondrodysplasias. 
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